The Global vascular graft devices Market was valued at USD 2.73 billion in 2021

Global Vascular Graft Devices Market was valued at USD 2.73 billion in 2021, growing at a CAGR of 6.38% during the forecast period from 2022 to 2027 to reach USD 3.96 billion by 2027. Factors such as the rising prevalence of lifestyle disorders such as hypertension and diabetes which present themselves as major risk factors for the development of cardiovascular diseases such as aortic aneurysms and peripheral artery disease, growing geriatric population base where age itself plays a major role in disease etiology, and technical innovation in product development such as manufacture of coated vascular graft devices with improved features among other factors are expected to drive the vascular graft devices market.

Vascular Graft Devices Market Companies
Some of the key market players operating in the vascular graft devices market includes BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH., Vascular Graft Solutions, and others.

Discover more about the Vascular Graft Device Report @ https://www.delveinsight.com/sample-request/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Vascular Graft Device Overview
Vascular grafting (also known as vascular bypass) is a surgical procedure that reconnects blood vessels to direct blood flow from one area of the body to another. It is done by using vascular grafts that serve as channels for creating alternate passage for establishing blood supply.

Recent Developmental Activities in Vascular Graft Devices Market:
• In October 2021, Terumo Aortic obtained the regulatory approval and the commercial launch of the Treo abdominal aortic stent graft system in Japan. The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) the Treo device as the treatment for abdominal aortic aneurysms.
• In June 2020, LeMaitre Vascular, Inc acquired the business and assets of Artegraft, Inc. for USD 90.0 million, thereby gaining access to Artegraft's portfolio of biologic vascular grafts.
• In March 2020, SCITECH received the regulatory approval for their product SOLARIS which is a vascular endograft aimed at treating peripheral vascular disease. The device received the CE mark.
Key Takeaways from the Vascular Graft Devices Market Report Study
• Market analysis for current vascular graft devices market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vascular graft devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global vascular graft devices market.
• Various opportunities available for the other competitor in the vascular graft devices market space.
• What are the top performing segments in 2021? How these segments will perform in 2027.
• Which is the top-performing regions and countries in the current vascular graft devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for vascular graft devices market growth in the coming future?

Learn more about the Vascular Graft Devices, get in-depth information of the report offering @ https://www.delveinsight.com/sample-request/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

COVID-19 Impact on Vascular Graft Devices Market Report
The vascular grafts market saw a decline in sales due to the implementation of measures to curb the global spread of COVID-19 infection. One of the key steps during the COVID surge was numerous selective treatments and suspension of outpatient consultations. This reduced the demand for such grafts in the market as healthcare system guidelines around the world were modified to temporarily focus on managing patients exposed to COVID-19 infection. Declining product demand was observed in the vascular graft market as supply chains and product manufacturing activities were affected around the world during the lockdown phase in 2020. However, the market seems to be in the process of recovery, with the global supply chain recovering and medical facility activity resuming, providing a positive outlook for the vascular graft devices market during the forecast period.

Sales in the vascular graft devices market declined due to the implementation of measures to curb the worldwide spread of COVID-19 infection. One of the most important steps during the COVID-19 pandemic was the halt in selective treatments and interruptions in outpatient visits. This reduced the market demand for such devices as the global healthcare system modified their work flow to accommodate the patient loaf associated with the COVID-19 infection. The product demand in the vascular grafts market witnessed a stunted growth during the 2020 lockdown period. However, with the recovery of the global supply chain and the medical resumption of institutional activities, the market appears to be in the process of recovery, providing a positive outlook for the vascular grafts market over the forecast period.

Vascular Graft Devices Market Segment Analysis
Vascular Graft Devices Market by Product Type (Endovascular Grafts [Abdominal and Thoracic], Access Grafts, Peripheral Grafts, and Others), by Type (Knitted, Woven, and Others), by Material (Synthetic [Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Others), by Geography (North America, Europe, Asia-Pacific, and Rest of the World). In the material segment of the vascular grafts market, the polytetrafluororthylene (PTFE) subcategory is estimated to account for a significant revenue share in the forecast period. PFTE grafts are comparatively less prone to infection and thrombosis, exhibit increased porosity, better adhesion and improved pliability in comparison with other grafts.
Moreover, the development of expanded PTFE (ePTFE) has also added to growth of this product category. Therefore, considering the advantages associated with the PTFE-based vascular grafts, this category is expected to account for a formidable market share in the vascular grafts market.

Read more about the Vascular Graft Devices Report offering- https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Vascular Graft Devices Market Report
• Coverage- Global
• Study Period- 2019-2027
• Companies- BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH, and others.
• Vascular Graft Devices Market by Product Type (Endovascular Grafts [Abdominal and Thoracic], Access Grafts, Peripheral Grafts, and Others)
• Vascular Graft Devices Market By Type (Knitted, Woven, and Others)
• Vascular Graft Devices Market By Material (Synthetic [Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, and Others)
• Vascular Graft Devices Market By End User (Hospitals, Ambulatory Surgical Centers, and Others)
• Vascular Graft Devices Market By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
• Porter's Five Forces Analysis, Product Profiles, Cases Studies, KOL's Views, and Analyst's Views

Table of Content
1. Vascular Graft Devices Market Report Introduction
2. Vascular Graft Devices Market Executive Summary
3. Regulatory Analysis
4. Vascular Graft Devices Market Key Factor Analysis
5. Vascular Graft Devices Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Vascular Graft Devices Market
7. Vascular Graft Devices Market Layout
8. Vascular Graft Devices Market Global Company Share Analysis - Key 3-5 Companies
9. Vascular Graft Devices Market Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us

Got Queries? Reach out for more in-depth details of the Vascular Graft Devices Market Report- https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Company Name: DelveInsight
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: +919650213330
Address: 304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.